Switzerland is a small open economy that is highly sensitive to foreign demand, meaning that the Trump administration’s recent tariff announcement has important ramifications for the country. Since 2 April, so-called Liberation Day, global trade developments have been worse than were expected at the beginning of the year. The outlook for Switzerland deteriorated, especially after the announcement on 1 August that Swiss goods shipped into the US would be subject to a 39% tariff rate.
Tariff impact on Swiss exports
That tariff rate is much higher than applied to goods from the UK (10%), the European Union and Japan (15%) putting Swiss companies at a clear disadvantage. However, pharmaceutical goods and gold are exempt from tariffs, mitigating the shock to the Swiss economy in aggregate. Indeed, in 2024, pharmaceuticals and gold accounted for just under 70% of total US imports from Switzerland.1 The value of goods exports from the sectors affected by the new tariffs represent just over 4% of total Swiss exports, or less than 2.5% of annual GDP.2